QMS Medical Allied Services FY24 PAT up by 41 Percent
Mumbai (Maharashtra) [India], May 25: QMS Medical Allied Services Limited (NSE: QMSMEDI), engaged in the marketing and distribution of a wide range of medical products, as well as prioritizing Patient Services Programs, has announced its Audited Financial Results for FY24 & Q4 FY24. Key Financial Highlights FY24 • Total Income of ₹ 122.58 Cr, YoY growth of 16.99% • EBITDA of ₹ 18.80 [...]
Mumbai (Maharashtra) [India], May 25: QMS Medical Allied Services Limited (NSE: QMSMEDI), engaged in the marketing and distribution of a wide range of medical products, as well as prioritizing Patient Services Programs, has announced its Audited Financial Results for FY24 & Q4 FY24.
Key Financial Highlights FY24
• Total Income of ₹ 122.58 Cr, YoY growth of 16.99%
• EBITDA of ₹ 18.80 Cr, YoY growth of 55.83%
• EBITDA Margin of 15.34%, YoY growth of 382 Bps
• PAT of ₹ 9.00 Cr, YoY growth of 41.14%
• PAT (%) of 7.34%, YoY growth of 126 Bps
• EPS of ₹ 5.04, YoY growth of 29.23%
Key Highlights For FY24
• The Company announced Final Dividend of ₹ 0.5 (5%) per share against the face value of ₹ 10 per share.
• The company reported operating cash flow of ₹ 1.36 Cr for FY24 an Vs ₹ (-7.54) Cr in FY23.
Commenting on the performance, Mr. Mahesh Makhija, Chairman and Managing Director, mentioned, “I am pleased to highlight the commendable growth trajectory of QMS Medical Allied Services Limited during the reported period. Our significant increase in financial performance has been driven by a surge in our patient service programs, efforts to widen healthcare access, and our commitment to advancing nationwide well-being.
Our recent acquisition of Saarthi Healthcare Private Limited will play a crucial role in our future & will enable us to provide a highly comprehensive portfolio of services further solidifying our industry position.
We are strategically expanding our healthcare services and reach, positioning ourselves to leverage opportunities within India’s burgeoning pharma and healthcare industry. Our commitment to innovation, patient outcomes, and sustainability will drive our continued success.”
Key Highlights For Q4 FY24
Conducted Patient Service Programs
• Conducted over 25,000 patient service programs in FY23-FY24. • Benefitted 2 lakh individuals nationwide with advanced diagnostics and lifestyle management consultations.
Saarathi Healthcare Acquisition
• Expands into patient services ve
If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.
